Moker P, Zur Stadt U, Zimmermann M, Alawi M, et al. Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia. Leukemia 2022 Jul 5. pii: 10.1038/s41375-022-01626.
PMID: 35790817